Enhanced gamma-carboxylation of recombinant vitamin K-dependent clotting factor
US7220849B2 · kind B2 · utility
21Cited by
0References
16Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jan 22, 2003 |
| Grant date | May 22, 2007 |
| Priority date | — |
| Expiry date | Jan 28, 2023 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to methods of optimizing gamma carboxylation of a vitamin K-dependent protein, methods of generating fully gamma carboxylated vitamin K-dependent protein, and compositions comprising chimeric nucleic acids and proteins for use in treatment of vitamin K-dependent disease states.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.